A 48-year-old man with chronic myeloid leukemia (CML) in chronic phase is started on imatinib mesylate. At 3 months, BCR-ABL transcript levels are detectable by quantitative PCR despite compliance. Which investigation is most appropriate to identify the mechanism of resistance?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.